Dynavax Technologies Corp financial data

Symbol
DVAX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2100 Powell Street, Suite 720, Emeryville, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.46K % +123%
Quick Ratio 96.7 % +88.1%
Debt-to-equity 59.7 % -20.5%
Return On Equity 2.76 % -86.1%
Return On Assets 1.73 % -84.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 131M shares +1.75%
Common Stock, Shares, Outstanding 131M shares +1.71%
Entity Public Float 900M USD -18.2%
Common Stock, Value, Issued 131K USD +1.55%
Weighted Average Number of Shares Outstanding, Basic 131M shares +1.78%
Weighted Average Number of Shares Outstanding, Diluted 154M shares +1.53%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 250M USD -45.6%
Research and Development Expense 56.7M USD +8.09%
Costs and Expenses 266M USD -27.9%
Operating Income (Loss) -15.9M USD -118%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 18.6M USD -83.5%
Income Tax Expense (Benefit) 1.37M USD -28.3%
Net Income (Loss) Attributable to Parent 17.2M USD -84.5%
Earnings Per Share, Basic 0.13 USD/shares -85.2%
Earnings Per Share, Diluted 0.12 USD/shares -83.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 113M USD -50.4%
Inventory, Net 62.5M USD +17.7%
Assets, Current 882M USD +10.6%
Property, Plant and Equipment, Net 36.1M USD -3.57%
Operating Lease, Right-of-Use Asset 22.5M USD -11.2%
Goodwill 2.01M USD -1.57%
Other Assets, Noncurrent 73.7M USD -0.33%
Assets 1.02B USD +8.53%
Accounts Payable, Current 4.56M USD +40.3%
Accrued Liabilities, Current 48.5M USD +43.2%
Liabilities, Current 62.2M USD +38.6%
Operating Lease, Liability, Noncurrent 27.5M USD -12.9%
Other Liabilities, Noncurrent 198K USD -43.3%
Liabilities 373M USD +3.97%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.91M USD +8.58%
Retained Earnings (Accumulated Deficit) -928M USD +1.82%
Stockholders' Equity Attributable to Parent 643M USD +11.4%
Liabilities and Equity 1.02B USD +8.53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.7M USD -160%
Net Cash Provided by (Used in) Financing Activities -4.2M USD -36%
Net Cash Provided by (Used in) Investing Activities 2.83M USD
Common Stock, Shares Authorized 278M shares 0%
Common Stock, Shares, Issued 131M shares +1.71%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.3M USD +34%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 113M USD -50.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 180M USD +0.82%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.24 pure +677%
Deferred Tax Assets, Gross 189M USD +0.38%
Operating Lease, Liability 32M USD -10.3%
Payments to Acquire Property, Plant, and Equipment 749K USD -41.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 17.6M USD -84.2%
Lessee, Operating Lease, Liability, to be Paid 44.1M USD -13.8%
Property, Plant and Equipment, Gross 69.1M USD +6.16%
Operating Lease, Liability, Current 4.54M USD +9.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.1M USD -10.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.96M USD -6.31%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.1M USD -21.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.03M USD +0.5%
Deferred Tax Assets, Operating Loss Carryforwards 96.3M USD -14.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 12.1M USD +6.72%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.2M USD +2.53%
Operating Lease, Payments 1.9M USD +11.8%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 9.04M USD -7.71%
Share-based Payment Arrangement, Expense 0 USD -100%
Interest Expense 6.78M USD +0.49%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%